[
  {
    "ts": "2025-12-18T18:31:15+00:00",
    "headline": "Hut 8 CEO says $7 billion data center deal with Google is 'first domino to fall'",
    "summary": "Hut 8 CEO Asher Genoot says a 15-year financial guarantee from Google was the key to unlocking billions in project financing from JPMorgan and Goldman Sachs.",
    "url": "https://finance.yahoo.com/news/hut-8-ceo-says-7-billion-data-center-deal-with-google-is-first-domino-to-fall-183115394.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "04318a83-17a8-41a1-8859-d2e69125ce18",
      "content": {
        "id": "04318a83-17a8-41a1-8859-d2e69125ce18",
        "contentType": "STORY",
        "title": "Hut 8 CEO says $7 billion data center deal with Google is 'first domino to fall'",
        "description": "",
        "summary": "Hut 8 CEO Asher Genoot says a 15-year financial guarantee from Google was the key to unlocking billions in project financing from JPMorgan and Goldman Sachs.",
        "pubDate": "2025-12-18T18:31:15Z",
        "displayTime": "2025-12-18T18:31:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-12/f8d59db0-dc32-11f0-abf5-a808ba6eb4d3",
          "originalWidth": 6665,
          "originalHeight": 4443,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jyBDsrMp.NrwTqqQLwHgew--~B/aD00NDQzO3c9NjY2NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-12/f8d59db0-dc32-11f0-abf5-a808ba6eb4d3.cf.webp",
              "width": 6665,
              "height": 4443,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0zEubud7_UykM6Z7R4dnHw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-12/f8d59db0-dc32-11f0-abf5-a808ba6eb4d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hut-8-ceo-says-7-billion-data-center-deal-with-google-is-first-domino-to-fall-183115394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hut-8-ceo-says-7-billion-data-center-deal-with-google-is-first-domino-to-fall-183115394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HUT"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "ANTH.PVT"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "ABTC"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T22:11:51+00:00",
    "headline": "JPMorgan Reinstates Palo Alto Networks (PANW) With Overweight Rating",
    "summary": "Palo Alto Networks, Inc. (NASDAQ:PANW) is included among the 12 Best Long Term US Stocks to Buy Now. On December 17, JPMorgan reinstated coverage of Palo Alto Networks, Inc. (NASDAQ:PANW) with an Overweight rating and a $235 price target. The move followed a period of restriction. The firm said Palo Alto offers one of the […]",
    "url": "https://finance.yahoo.com/news/bofa-adjusts-elevance-health-elv-221151681.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "021b1036-eba1-3fd7-a094-5f76b39303ce",
      "content": {
        "id": "021b1036-eba1-3fd7-a094-5f76b39303ce",
        "contentType": "STORY",
        "title": "JPMorgan Reinstates Palo Alto Networks (PANW) With Overweight Rating",
        "description": "",
        "summary": "Palo Alto Networks, Inc. (NASDAQ:PANW) is included among the 12 Best Long Term US Stocks to Buy Now. On December 17, JPMorgan reinstated coverage of Palo Alto Networks, Inc. (NASDAQ:PANW) with an Overweight rating and a $235 price target. The move followed a period of restriction. The firm said Palo Alto offers one of the […]",
        "pubDate": "2025-12-18T22:11:51Z",
        "displayTime": "2025-12-18T22:11:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/04caa8cac5e9f4a148679077496305c9",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "JPMorgan Reinstates Palo Alto Networks (PANW) With Overweight Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t8BuRzwJXJpxkGChIVs8IA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/04caa8cac5e9f4a148679077496305c9.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x6XdYrCKet32lj37bVt.fg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/04caa8cac5e9f4a148679077496305c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bofa-adjusts-elevance-health-elv-221151681.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bofa-adjusts-elevance-health-elv-221151681.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PANW"
            },
            {
              "symbol": "ELV"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T21:05:00+00:00",
    "headline": "Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026",
    "summary": "SAN DIEGO, December 18, 2025--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive Officer will represent the company in a session scheduled on Tuesday, January 13, 2026, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time.",
    "url": "https://finance.yahoo.com/news/acadia-pharmaceuticals-present-44th-annual-210500795.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8b6e357c-50cd-3104-b210-8835fc073b81",
      "content": {
        "id": "8b6e357c-50cd-3104-b210-8835fc073b81",
        "contentType": "STORY",
        "title": "Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026",
        "description": "",
        "summary": "SAN DIEGO, December 18, 2025--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive Officer will represent the company in a session scheduled on Tuesday, January 13, 2026, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time.",
        "pubDate": "2025-12-18T21:05:00Z",
        "displayTime": "2025-12-18T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/1427bac54ae720ea0244586c869b936c",
          "originalWidth": 800,
          "originalHeight": 307,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YTajJAFE2MXFz1F0bkeXEg--~B/aD0zMDc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1427bac54ae720ea0244586c869b936c.cf.webp",
              "width": 800,
              "height": 307,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dyyx2g3Sc8SbbW9q7dVc.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1427bac54ae720ea0244586c869b936c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/acadia-pharmaceuticals-present-44th-annual-210500795.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/acadia-pharmaceuticals-present-44th-annual-210500795.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACAD"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T21:05:00+00:00",
    "headline": "Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "HAYWARD, Calif., December 18, 2025--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, announced that Terry Rosen, Ph.D., chief executive officer, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The presentation will take place on Wednesday, January 14th, 2026, at 3:00 pm PT.",
    "url": "https://finance.yahoo.com/news/arcus-biosciences-participate-44th-annual-210500947.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "12e54aa0-e227-3d57-afce-9c222b3663e8",
      "content": {
        "id": "12e54aa0-e227-3d57-afce-9c222b3663e8",
        "contentType": "STORY",
        "title": "Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "HAYWARD, Calif., December 18, 2025--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, announced that Terry Rosen, Ph.D., chief executive officer, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The presentation will take place on Wednesday, January 14th, 2026, at 3:00 pm PT.",
        "pubDate": "2025-12-18T21:05:00Z",
        "displayTime": "2025-12-18T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arcus-biosciences-participate-44th-annual-210500947.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arcus-biosciences-participate-44th-annual-210500947.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RCUS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T20:14:12+00:00",
    "headline": "How Recent Moves Are Rewriting the Growth Story for Wolters Kluwer",
    "summary": "Wolters Kluwer's latest valuation update reflects a slightly lower fair value estimate of €138.00, driven by marginally more conservative assumptions around its long term outlook. The move comes amid successive target reductions from major brokers like JPMorgan, which see the shares as fairly valued with more limited upside, even as the company’s resilient recurring revenue and strong competitive position continue to anchor sentiment. Stay tuned to see how investors can track these subtle...",
    "url": "https://finance.yahoo.com/news/recent-moves-rewriting-growth-story-201412703.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "388879a7-0789-3a8c-8ec0-6ddb19a95863",
      "content": {
        "id": "388879a7-0789-3a8c-8ec0-6ddb19a95863",
        "contentType": "STORY",
        "title": "How Recent Moves Are Rewriting the Growth Story for Wolters Kluwer",
        "description": "",
        "summary": "Wolters Kluwer's latest valuation update reflects a slightly lower fair value estimate of €138.00, driven by marginally more conservative assumptions around its long term outlook. The move comes amid successive target reductions from major brokers like JPMorgan, which see the shares as fairly valued with more limited upside, even as the company’s resilient recurring revenue and strong competitive position continue to anchor sentiment. Stay tuned to see how investors can track these subtle...",
        "pubDate": "2025-12-18T20:14:12Z",
        "displayTime": "2025-12-18T20:14:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/51efc4c16661a09e764445427d52ecc6",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_sSFGAm8gbELAg8wSIb8Hw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/51efc4c16661a09e764445427d52ecc6.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nUVuxY3DAU6u1dFSsS08Pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/51efc4c16661a09e764445427d52ecc6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-moves-rewriting-growth-story-201412703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-moves-rewriting-growth-story-201412703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WOLTF"
            },
            {
              "symbol": "WTKWY"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T19:56:59+00:00",
    "headline": "These Techs Had The Biggest Stock Buybacks In Q3. What To Expect In 2026.",
    "summary": "Third-quarter buybacks rose 9.9% vs. a year earlier to $249 billion. Apple, Nvidia, Google and Meta Platforms led the way.",
    "url": "https://www.investors.com/news/stock-buybacks-apple-meta-nvidia-google/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "611058f2-bd02-3aaa-8359-ae75b01ba04c",
      "content": {
        "id": "611058f2-bd02-3aaa-8359-ae75b01ba04c",
        "contentType": "STORY",
        "title": "These Techs Had The Biggest Stock Buybacks In Q3. What To Expect In 2026.",
        "description": "",
        "summary": "Third-quarter buybacks rose 9.9% vs. a year earlier to $249 billion. Apple, Nvidia, Google and Meta Platforms led the way.",
        "pubDate": "2025-12-18T19:56:59Z",
        "displayTime": "2025-12-18T19:56:59Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/611058f2-bd02-3aaa-8359-ae75b01ba04c/these-techs-had-the-biggest.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/ecfb9cf4b455aa1eed41aa0d015b94e0",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IXeRjiadVC.Cg6JmSmyiWg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/ecfb9cf4b455aa1eed41aa0d015b94e0.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gELpaPHY58zf2da3NmDKnw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/ecfb9cf4b455aa1eed41aa0d015b94e0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/stock-buybacks-apple-meta-nvidia-google/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "GOOG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T19:24:18+00:00",
    "headline": "Can the S&P 500 Get to 8000? These Experts Say Yes—But It'll Take Big Rate Cuts",
    "summary": "The bank's year-end target for the S&P 500 is underpinned by an expectation of two more rate cuts and a pause.",
    "url": "https://www.investopedia.com/can-the-s-and-p-500-get-to-8000-these-experts-say-yes-but-it-ll-take-big-rate-cuts-11872292",
    "source": "Investopedia",
    "provider": "yfinance",
    "raw": {
      "id": "fdff12a5-290a-32ab-8ad2-c4729cac71ac",
      "content": {
        "id": "fdff12a5-290a-32ab-8ad2-c4729cac71ac",
        "contentType": "STORY",
        "title": "Can the S&P 500 Get to 8000? These Experts Say Yes—But It'll Take Big Rate Cuts",
        "description": "",
        "summary": "The bank's year-end target for the S&P 500 is underpinned by an expectation of two more rate cuts and a pause.",
        "pubDate": "2025-12-18T19:24:18Z",
        "displayTime": "2025-12-18T19:24:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/investopedia_245/95bc1aaeec91773126d854bafb12878c",
          "originalWidth": 8192,
          "originalHeight": 5464,
          "caption": "Michael Nagle / Bloomberg via Getty Images",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0IQ3jQAs84o3mexMFEtZrQ--~B/aD01NDY0O3c9ODE5MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/95bc1aaeec91773126d854bafb12878c.cf.webp",
              "width": 8192,
              "height": 5464,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gZI8PQsMtzKew2AnTyrTvg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investopedia_245/95bc1aaeec91773126d854bafb12878c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investopedia",
          "url": "https://www.investopedia.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investopedia.com/can-the-s-and-p-500-get-to-8000-these-experts-say-yes-but-it-ll-take-big-rate-cuts-11872292",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/p-500-8000-experts-yes-192418126.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T18:51:43+00:00",
    "headline": "Sector Update: Financial Stocks Advance Thursday Afternoon",
    "summary": "Financial stocks were higher in Thursday afternoon trading, with the NYSE Financial Index increasing",
    "url": "https://finance.yahoo.com/news/sector-financial-stocks-advance-thursday-185143607.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "fe3e7c8e-36c9-3b8d-8701-bc03e65db5e7",
      "content": {
        "id": "fe3e7c8e-36c9-3b8d-8701-bc03e65db5e7",
        "contentType": "STORY",
        "title": "Sector Update: Financial Stocks Advance Thursday Afternoon",
        "description": "",
        "summary": "Financial stocks were higher in Thursday afternoon trading, with the NYSE Financial Index increasing",
        "pubDate": "2025-12-18T18:51:43Z",
        "displayTime": "2025-12-18T18:51:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-financial-stocks-advance-thursday-185143607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-financial-stocks-advance-thursday-185143607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "XLRE"
            },
            {
              "symbol": "XLF"
            },
            {
              "symbol": "CVBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T17:31:12+00:00",
    "headline": "JPMorgan Warns: AI Hype Has Peaked — 2026 Is About Profits",
    "summary": "Generative AI dominated narratives in 2025, but the financial payoff hasn't kept pace with the hype. JPMorgan's 2026 outlook, backed by new CEO survey data, suggests markets are now recalibrating expectations — shifting focus from AI adoption to whether it actually delivers profits. GenAI Fell Short Of CEO Expectations PwC's latest global CEO survey, covering more than 4,700 executives across 109 countries, shows a clear expectation gap. While over 40% of CEOs entered 2025 expecting GenAI to boo",
    "url": "https://finance.yahoo.com/news/jpmorgan-warns-ai-hype-peaked-173112523.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "ccc0ce70-e3ba-3ade-8af0-5ad855cd0433",
      "content": {
        "id": "ccc0ce70-e3ba-3ade-8af0-5ad855cd0433",
        "contentType": "STORY",
        "title": "JPMorgan Warns: AI Hype Has Peaked — 2026 Is About Profits",
        "description": "",
        "summary": "Generative AI dominated narratives in 2025, but the financial payoff hasn't kept pace with the hype. JPMorgan's 2026 outlook, backed by new CEO survey data, suggests markets are now recalibrating expectations — shifting focus from AI adoption to whether it actually delivers profits. GenAI Fell Short Of CEO Expectations PwC's latest global CEO survey, covering more than 4,700 executives across 109 countries, shows a clear expectation gap. While over 40% of CEOs entered 2025 expecting GenAI to boo",
        "pubDate": "2025-12-18T17:31:12Z",
        "displayTime": "2025-12-18T17:31:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/4b3533788243c30ce3164989c04fd5c3",
          "originalWidth": 1024,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tctZTj6gASUr0cJoPgtC0g--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/4b3533788243c30ce3164989c04fd5c3.cf.webp",
              "width": 1024,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OGJBPfzl1MzKb7J_2mN0gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/4b3533788243c30ce3164989c04fd5c3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-warns-ai-hype-peaked-173112523.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-warns-ai-hype-peaked-173112523.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "AMZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T16:51:00+00:00",
    "headline": "SCOR renews its contingent capital program",
    "summary": "Press release18 December 2025 - N° 20 SCOR renews its contingent capital program Disclaimer: SCOR (hereafter “SCOR” or the “Company”) has implemented a contingent capital program in the form of share subscription warrants with J.P. Morgan SE, which upon exercise of these warrants after having received the issued shares is not intended to remain a shareholder of the Company. The Company's ordinary shares, which would result from the exercise of the aforementioned share subscription warrants, will",
    "url": "https://finance.yahoo.com/news/scor-renews-contingent-capital-program-165100376.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "047e8654-dbe9-3b80-b219-beca448b7fb5",
      "content": {
        "id": "047e8654-dbe9-3b80-b219-beca448b7fb5",
        "contentType": "STORY",
        "title": "SCOR renews its contingent capital program",
        "description": "",
        "summary": "Press release18 December 2025 - N° 20 SCOR renews its contingent capital program Disclaimer: SCOR (hereafter “SCOR” or the “Company”) has implemented a contingent capital program in the form of share subscription warrants with J.P. Morgan SE, which upon exercise of these warrants after having received the issued shares is not intended to remain a shareholder of the Company. The Company's ordinary shares, which would result from the exercise of the aforementioned share subscription warrants, will",
        "pubDate": "2025-12-18T16:51:00Z",
        "displayTime": "2025-12-18T16:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/374198528bce8edf7c101fac21f12fd0",
          "originalWidth": 248,
          "originalHeight": 70,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L1ONq2fiFguyFArvc3Bg1w--~B/aD03MDt3PTI0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/374198528bce8edf7c101fac21f12fd0.cf.webp",
              "width": 248,
              "height": 70,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FFEVhz2srWhzxsGNi.lLXw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/374198528bce8edf7c101fac21f12fd0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/scor-renews-contingent-capital-program-165100376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/scor-renews-contingent-capital-program-165100376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SCRYY"
            },
            {
              "symbol": "SZCRF"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T15:53:00+00:00",
    "headline": "Trump Might Limit Defense-Stock Dividends. That’s a Bad Idea.",
    "summary": "President Donald Trump is playing Santa Claus.  The president is considering an executive order that would limit defense companies’ ability to pay dividends or buy back stock if projects are behind schedule or over budget, according to a report from Reuters.  The White House didn’t immediately respond to a request for comment.",
    "url": "https://www.barrons.com/articles/trump-dividends-defense-stocks-0ecf6d3e?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "83de6f12-2d73-3041-b527-b423bc5a66d1",
      "content": {
        "id": "83de6f12-2d73-3041-b527-b423bc5a66d1",
        "contentType": "STORY",
        "title": "Trump Might Limit Defense-Stock Dividends. That’s a Bad Idea.",
        "description": "",
        "summary": "President Donald Trump is playing Santa Claus.  The president is considering an executive order that would limit defense companies’ ability to pay dividends or buy back stock if projects are behind schedule or over budget, according to a report from Reuters.  The White House didn’t immediately respond to a request for comment.",
        "pubDate": "2025-12-18T15:53:00Z",
        "displayTime": "2025-12-18T15:53:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/83de6f12-2d73-3041-b527-b423bc5a66d1/trump-might-limit.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/d58fbef9203098202acada733de66547",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gu2BNs2vwr6AC535hBwl3A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/d58fbef9203098202acada733de66547.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NqbxlplH2DIFSnpx9eGz8w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/d58fbef9203098202acada733de66547.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/trump-dividends-defense-stocks-0ecf6d3e?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "EADSF"
            },
            {
              "symbol": "EADSY"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "ITA"
            },
            {
              "symbol": "BA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T15:42:00+00:00",
    "headline": "Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, December 18, 2025--Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for health challenges faced by hundreds of millions of people globally, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference to be held January 12-15 in San Francisco, CA.",
    "url": "https://finance.yahoo.com/news/kallyope-present-44th-annual-j-113000425.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "64728463-583b-3467-a950-c23d3a1d340e",
      "content": {
        "id": "64728463-583b-3467-a950-c23d3a1d340e",
        "contentType": "STORY",
        "title": "Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "NEW YORK, December 18, 2025--Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for health challenges faced by hundreds of millions of people globally, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference to be held January 12-15 in San Francisco, CA.",
        "pubDate": "2025-12-18T15:42:00Z",
        "displayTime": "2025-12-18T15:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/cea07e11741836c70b5a63b69b17b159",
          "originalWidth": 480,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xB4axT1wfwQcZzOWCQQ15g--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cea07e11741836c70b5a63b69b17b159.cf.webp",
              "width": 480,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/z3OGwOaqsfiJkNbe19gmug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cea07e11741836c70b5a63b69b17b159.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kallyope-present-44th-annual-j-113000425.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kallyope-present-44th-annual-j-113000425.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T15:41:19+00:00",
    "headline": "Is JPMorgan Chase (JPM) Still Undervalued After Its Strong 31% Year‑to‑Date Rally?",
    "summary": "JPMorgan Chase (JPM) has quietly added to its gains this year, with the stock up roughly 31% year to date and nearly 40% over the past year, outpacing many large bank peers. See our latest analysis for JPMorgan Chase. That steady climb has come as investors warm to JPMorgan Chase’s scale advantages and solid credit quality, with the share price now at $314.98 and building momentum after a strong year to date share price return and powerful multi year total shareholder returns. If JPMorgan’s...",
    "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-still-undervalued-154119800.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "88d8bfb3-c651-3e60-9b9e-9bb3fc1e8b9e",
      "content": {
        "id": "88d8bfb3-c651-3e60-9b9e-9bb3fc1e8b9e",
        "contentType": "STORY",
        "title": "Is JPMorgan Chase (JPM) Still Undervalued After Its Strong 31% Year‑to‑Date Rally?",
        "description": "",
        "summary": "JPMorgan Chase (JPM) has quietly added to its gains this year, with the stock up roughly 31% year to date and nearly 40% over the past year, outpacing many large bank peers. See our latest analysis for JPMorgan Chase. That steady climb has come as investors warm to JPMorgan Chase’s scale advantages and solid credit quality, with the share price now at $314.98 and building momentum after a strong year to date share price return and powerful multi year total shareholder returns. If JPMorgan’s...",
        "pubDate": "2025-12-18T15:41:19Z",
        "displayTime": "2025-12-18T15:41:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/buiFSDj_0ot5Q6v9J14wWA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jnehXQ3eKjDwH262Ddswdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-still-undervalued-154119800.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-still-undervalued-154119800.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T14:00:00+00:00",
    "headline": "Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference",
    "summary": "- The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones -JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (\"Alpha Tau\", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CEO Uzi Sofer and CFO Raphi Levy will present a corporate overview and update at the J.P. Morgan 2026 Healthcare Conference on Thursday, January",
    "url": "https://finance.yahoo.com/news/alpha-tau-present-j-p-140000514.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d6c125cd-8791-3797-81f4-c54297c0bc8d",
      "content": {
        "id": "d6c125cd-8791-3797-81f4-c54297c0bc8d",
        "contentType": "STORY",
        "title": "Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference",
        "description": "",
        "summary": "- The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones -JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (\"Alpha Tau\", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CEO Uzi Sofer and CFO Raphi Levy will present a corporate overview and update at the J.P. Morgan 2026 Healthcare Conference on Thursday, January",
        "pubDate": "2025-12-18T14:00:00Z",
        "displayTime": "2025-12-18T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5cf2b488ac4ae5ead35081f2ba0dadbe",
          "originalWidth": 320,
          "originalHeight": 229,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pvjAF9q7.gGWyi6GT_tAcQ--~B/aD0yMjk7dz0zMjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5cf2b488ac4ae5ead35081f2ba0dadbe.cf.webp",
              "width": 320,
              "height": 229,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SHombK6uJOgt4hht_6ooaA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5cf2b488ac4ae5ead35081f2ba0dadbe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alpha-tau-present-j-p-140000514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alpha-tau-present-j-p-140000514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "DRTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:57:00+00:00",
    "headline": "A Trillion Reasons to Watch MarketAxess in Emerging Markets",
    "summary": "MKTX tops $1T in emerging markets trading in 2025, with record volumes, full index coverage and expanding electronic access across local and hard currency bonds.",
    "url": "https://finance.yahoo.com/news/trillion-reasons-watch-marketaxess-emerging-135700134.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "0bf1a0c8-c81b-3f34-bb24-757a3dd7677e",
      "content": {
        "id": "0bf1a0c8-c81b-3f34-bb24-757a3dd7677e",
        "contentType": "STORY",
        "title": "A Trillion Reasons to Watch MarketAxess in Emerging Markets",
        "description": "",
        "summary": "MKTX tops $1T in emerging markets trading in 2025, with record volumes, full index coverage and expanding electronic access across local and hard currency bonds.",
        "pubDate": "2025-12-18T13:57:00Z",
        "displayTime": "2025-12-18T13:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/8c0fc26d3015a524f75a0687c0fc8ceb",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFGtHs0R6xuczQBWBMm42A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8c0fc26d3015a524f75a0687c0fc8ceb.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f.dihueNxxCIELdVEzXwrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8c0fc26d3015a524f75a0687c0fc8ceb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trillion-reasons-watch-marketaxess-emerging-135700134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trillion-reasons-watch-marketaxess-emerging-135700134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MKTX"
            },
            {
              "symbol": "ICE"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:30:00+00:00",
    "headline": "Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "PARSIPPANY, N.J., December 18, 2025--Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 10:30 a.m. PT.",
    "url": "https://finance.yahoo.com/news/zoetis-participate-44th-annual-j-133000360.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "7b5d06da-dbae-3685-a597-b49526558430",
      "content": {
        "id": "7b5d06da-dbae-3685-a597-b49526558430",
        "contentType": "STORY",
        "title": "Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "PARSIPPANY, N.J., December 18, 2025--Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 10:30 a.m. PT.",
        "pubDate": "2025-12-18T13:30:00Z",
        "displayTime": "2025-12-18T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3b245a4a3eace50f0bfd6e7934690eae",
          "originalWidth": 1035,
          "originalHeight": 387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EHiULe56n4nenHIInWYV0g--~B/aD0zODc7dz0xMDM1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3b245a4a3eace50f0bfd6e7934690eae.cf.webp",
              "width": 1035,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fa1BXkCz8V4MxWaYVJfbTw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3b245a4a3eace50f0bfd6e7934690eae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-participate-44th-annual-j-133000360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-participate-44th-annual-j-133000360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 9 a.m. PST/12 p.m. EST.",
    "url": "https://finance.yahoo.com/news/ptc-therapeutics-present-44th-annual-130000639.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "716450a9-57c5-30a3-b90f-237111057033",
      "content": {
        "id": "716450a9-57c5-30a3-b90f-237111057033",
        "contentType": "STORY",
        "title": "PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 9 a.m. PST/12 p.m. EST.",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63",
          "originalWidth": 400,
          "originalHeight": 244,
          "caption": "PTC Therapeutics, Inc. Logo (PRNewsfoto/PTC Therapeutics, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y8Qnhpz6m1dkuaR9LG7gIg--~B/aD0yNDQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63.cf.webp",
              "width": 400,
              "height": 244,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fMf2sn5IjgE8culMEnxjBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-present-44th-annual-130000639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-present-44th-annual-130000639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTCT"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "PTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference",
    "summary": "SOUTH SAN FRANCISCO, Calif., December 18, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026 at 2:15 pm Pacific Time in San Francisco.",
    "url": "https://finance.yahoo.com/news/twist-bioscience-present-j-p-130000909.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "f50826ec-08de-3710-bc43-c9c233f3fad7",
      "content": {
        "id": "f50826ec-08de-3710-bc43-c9c233f3fad7",
        "contentType": "STORY",
        "title": "Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference",
        "description": "",
        "summary": "SOUTH SAN FRANCISCO, Calif., December 18, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026 at 2:15 pm Pacific Time in San Francisco.",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/0ad9ec567e69329a8dbe9c757bb06585",
          "originalWidth": 480,
          "originalHeight": 240,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KKFguBbTWG6zEDh5ipXkdA--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0ad9ec567e69329a8dbe9c757bb06585.cf.webp",
              "width": 480,
              "height": 240,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mU3gox5cX9Rg4vJmhwFYxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0ad9ec567e69329a8dbe9c757bb06585.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/twist-bioscience-present-j-p-130000909.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/twist-bioscience-present-j-p-130000909.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TWST"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "Revvity to Present at J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., December 18, 2025--Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT.",
    "url": "https://finance.yahoo.com/news/revvity-present-j-p-morgan-130000967.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2988d2c4-c965-37fb-bdfd-ce6118ba2080",
      "content": {
        "id": "2988d2c4-c965-37fb-bdfd-ce6118ba2080",
        "contentType": "STORY",
        "title": "Revvity to Present at J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass., December 18, 2025--Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT.",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/582b4bfd3bebefdbbc1f07e46ac64762",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JPDrgamZJqp2fRrRbgdKjg--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/582b4bfd3bebefdbbc1f07e46ac64762.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dZye7jL_To_28PwboI9T7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/582b4bfd3bebefdbbc1f07e46ac64762.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-present-j-p-morgan-130000967.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-present-j-p-morgan-130000967.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "Calyxo, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "PLEASANTON, Calif., December 18, 2025--Calyxo, Inc., a medical device company advancing innovative solutions for kidney stone treatment, announced today that Joe Catanese, Ph.D., Chief Executive Officer of Calyxo will present at the J.P. Morgan 44th Annual Healthcare Conference on Monday, January 12, 2026, at 8:30 AM PT in San Francisco, CA.",
    "url": "https://finance.yahoo.com/news/calyxo-inc-present-44th-annual-130000968.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "92ab4bc4-30c6-36be-b405-07d759460171",
      "content": {
        "id": "92ab4bc4-30c6-36be-b405-07d759460171",
        "contentType": "STORY",
        "title": "Calyxo, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "PLEASANTON, Calif., December 18, 2025--Calyxo, Inc., a medical device company advancing innovative solutions for kidney stone treatment, announced today that Joe Catanese, Ph.D., Chief Executive Officer of Calyxo will present at the J.P. Morgan 44th Annual Healthcare Conference on Monday, January 12, 2026, at 8:30 AM PT in San Francisco, CA.",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/fd0ccaac2d6a77470edf90773b83753f",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qgrljrg79jwFiWOTnz4XbA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/fd0ccaac2d6a77470edf90773b83753f.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZJCEhfrvQSYzdeCzg0ZhNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fd0ccaac2d6a77470edf90773b83753f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/calyxo-inc-present-44th-annual-130000968.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/calyxo-inc-present-44th-annual-130000968.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "Abdera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13",
    "summary": "SOUTH SAN FRANCISCO, Calif., December 18, 2025--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced that Lori Lyons-Williams, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 10:00 a.m. PT.",
    "url": "https://finance.yahoo.com/news/abdera-therapeutics-present-44th-annual-130000445.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "9e5e3f6d-1759-3833-bb08-4856e28a9a8b",
      "content": {
        "id": "9e5e3f6d-1759-3833-bb08-4856e28a9a8b",
        "contentType": "STORY",
        "title": "Abdera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13",
        "description": "",
        "summary": "SOUTH SAN FRANCISCO, Calif., December 18, 2025--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced that Lori Lyons-Williams, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 10:00 a.m. PT.",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/acbace18fbf5d8a721e8a80533f6092d",
          "originalWidth": 1065,
          "originalHeight": 270,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WRAtNFBtQnGuhP6TYJKr8A--~B/aD0yNzA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/acbace18fbf5d8a721e8a80533f6092d.cf.webp",
              "width": 1065,
              "height": 270,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hdS2Lik_QiMmIs54r40iRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/acbace18fbf5d8a721e8a80533f6092d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abdera-therapeutics-present-44th-annual-130000445.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abdera-therapeutics-present-44th-annual-130000445.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T12:30:00+00:00",
    "headline": "Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference",
    "summary": "WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the J.P. Morgan 2026 Healthcare Conference, being held January 12 – 15 in San Francisco. Olivier Loeillot, President and Chief Executive Officer, will present an overview of the company on Tuesday, January 13 at 2:15 p.m. PT. A live webcast of the conference presentations will be accessible throug",
    "url": "https://finance.yahoo.com/news/repligen-corporation-present-j-p-123000457.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "66318f49-875c-337f-a231-2616de7a5ff9",
      "content": {
        "id": "66318f49-875c-337f-a231-2616de7a5ff9",
        "contentType": "STORY",
        "title": "Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the J.P. Morgan 2026 Healthcare Conference, being held January 12 – 15 in San Francisco. Olivier Loeillot, President and Chief Executive Officer, will present an overview of the company on Tuesday, January 13 at 2:15 p.m. PT. A live webcast of the conference presentations will be accessible throug",
        "pubDate": "2025-12-18T12:30:00Z",
        "displayTime": "2025-12-18T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e71fac2374bef21d032e92ac9c69f767",
          "originalWidth": 500,
          "originalHeight": 142,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iJPDCqct3WvB1x2xGw5EHg--~B/aD0xNDI7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e71fac2374bef21d032e92ac9c69f767.cf.webp",
              "width": 500,
              "height": 142,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tBeY4TMwqf8a4UZ9EStc6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e71fac2374bef21d032e92ac9c69f767.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/repligen-corporation-present-j-p-123000457.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/repligen-corporation-present-j-p-123000457.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RGEN"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T12:01:00+00:00",
    "headline": "MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, December 18, 2025--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \"Company\" or \"MindMed\"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that Rob Barrow, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT.",
    "url": "https://finance.yahoo.com/news/mindmed-present-44th-annual-j-120100744.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "195405d4-e82a-385d-98c0-92c99df97b88",
      "content": {
        "id": "195405d4-e82a-385d-98c0-92c99df97b88",
        "contentType": "STORY",
        "title": "MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "NEW YORK, December 18, 2025--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \"Company\" or \"MindMed\"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that Rob Barrow, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT.",
        "pubDate": "2025-12-18T12:01:00Z",
        "displayTime": "2025-12-18T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/ad98f466ea0990f352af78631b21ffb5",
          "originalWidth": 480,
          "originalHeight": 403,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.jyS_bm.rK1HpCXswN43.A--~B/aD00MDM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ad98f466ea0990f352af78631b21ffb5.cf.webp",
              "width": 480,
              "height": 403,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y.eN826wfGSITfqcszNENw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ad98f466ea0990f352af78631b21ffb5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mindmed-present-44th-annual-j-120100744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mindmed-present-44th-annual-j-120100744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "MNMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T12:00:00+00:00",
    "headline": "Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today announced that management plans to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 11:15 a.m. PST / 2:15 p.m. EST. A live and archived webca",
    "url": "https://finance.yahoo.com/news/rapport-therapeutics-present-44th-annual-120000759.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7cfe09f7-5098-3884-8b7f-0b7314557e0d",
      "content": {
        "id": "7cfe09f7-5098-3884-8b7f-0b7314557e0d",
        "contentType": "STORY",
        "title": "Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today announced that management plans to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 11:15 a.m. PST / 2:15 p.m. EST. A live and archived webca",
        "pubDate": "2025-12-18T12:00:00Z",
        "displayTime": "2025-12-18T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/bcfc377a473266a995d9d5593aaa95d7",
          "originalWidth": 4070,
          "originalHeight": 2069,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mx9cs9WTDDNYXqbIkNfqhg--~B/aD0yMDY5O3c9NDA3MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/bcfc377a473266a995d9d5593aaa95d7.cf.webp",
              "width": 4070,
              "height": 2069,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VyMoAfU4nFztbFtK.0JItQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcfc377a473266a995d9d5593aaa95d7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rapport-therapeutics-present-44th-annual-120000759.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rapport-therapeutics-present-44th-annual-120000759.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RAPP"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T12:00:00+00:00",
    "headline": "Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SEATTLE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (\"Perspective\" or the \"Company\") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that Thijs Spoor, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14, 2026, at 2:15 p.m. PT. 44th Annual J.P. Morgan Healthcare Conference – Company Presentation",
    "url": "https://finance.yahoo.com/news/perspective-therapeutics-present-44th-annual-120000571.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "08c2d316-4073-3723-b4c4-fa726fca1112",
      "content": {
        "id": "08c2d316-4073-3723-b4c4-fa726fca1112",
        "contentType": "STORY",
        "title": "Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SEATTLE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (\"Perspective\" or the \"Company\") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that Thijs Spoor, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14, 2026, at 2:15 p.m. PT. 44th Annual J.P. Morgan Healthcare Conference – Company Presentation",
        "pubDate": "2025-12-18T12:00:00Z",
        "displayTime": "2025-12-18T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f",
          "originalWidth": 624,
          "originalHeight": 131,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GNGkjH__517mGnV_oqTm_Q--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f.cf.webp",
              "width": 624,
              "height": 131,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1hW.gqtaupVUjQ2Q8sbZ8w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/perspective-therapeutics-present-44th-annual-120000571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/perspective-therapeutics-present-44th-annual-120000571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CATX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T11:56:00+00:00",
    "headline": "BNP Paribas Primary New Issues: Post-Stab No Stab Notice: ZENITA (Maticmind SPA)",
    "summary": "[18.12.2025] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [Zenita (Maticmind SPA)] Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated [12.12.2025] BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/",
    "url": "https://finance.yahoo.com/news/bnp-paribas-primary-issues-post-115600073.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f1642968-cc4f-33fc-9094-e0a49063962a",
      "content": {
        "id": "f1642968-cc4f-33fc-9094-e0a49063962a",
        "contentType": "STORY",
        "title": "BNP Paribas Primary New Issues: Post-Stab No Stab Notice: ZENITA (Maticmind SPA)",
        "description": "",
        "summary": "[18.12.2025] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [Zenita (Maticmind SPA)] Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated [12.12.2025] BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/",
        "pubDate": "2025-12-18T11:56:00Z",
        "displayTime": "2025-12-18T11:56:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c1ba25ef80ff0c284c3576066eb58771",
          "originalWidth": 335,
          "originalHeight": 73,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2kCy8mE3oJuuahqqBtvEUA--~B/aD03Mzt3PTMzNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c1ba25ef80ff0c284c3576066eb58771.cf.webp",
              "width": 335,
              "height": 73,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A7WbESNhL_31gBDG4utGiA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1ba25ef80ff0c284c3576066eb58771.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bnp-paribas-primary-issues-post-115600073.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bnp-paribas-primary-issues-post-115600073.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNPQF"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "UNCFF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T11:23:28+00:00",
    "headline": "Market Chatter: Banks Win Bid to Block $3.2 Billion Foreign Exchange Rigging Lawsuit in UK",
    "summary": "Major banks, including JPMorgan (JPM), UBS (UBS), and Citigroup (C), won a court ruling to block a 2",
    "url": "https://finance.yahoo.com/news/market-chatter-banks-win-bid-112328342.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "6b71f583-6296-3f5f-9648-e322cd3a8420",
      "content": {
        "id": "6b71f583-6296-3f5f-9648-e322cd3a8420",
        "contentType": "STORY",
        "title": "Market Chatter: Banks Win Bid to Block $3.2 Billion Foreign Exchange Rigging Lawsuit in UK",
        "description": "",
        "summary": "Major banks, including JPMorgan (JPM), UBS (UBS), and Citigroup (C), won a court ruling to block a 2",
        "pubDate": "2025-12-18T11:23:28Z",
        "displayTime": "2025-12-18T11:23:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-banks-win-bid-112328342.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-banks-win-bid-112328342.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "8306.T"
            },
            {
              "symbol": "BCS"
            },
            {
              "symbol": "NWG"
            },
            {
              "symbol": "MUFG"
            },
            {
              "symbol": "UBS"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T11:08:07+00:00",
    "headline": "How Recent Developments Are Reshaping The Postal Realty Trust Investment Story",
    "summary": "Postal Realty Trust has seen its fair value estimate inch higher from $16.66 to $17.93 per share as analysts factor in faster rental income growth and better cash flow visibility across its portfolio. A modest drop in the discount rate from 7.94% to about 7.50% has also boosted the present value of expected cash flows, even as some forecasts still build in cautious assumptions on long term growth and risk. Read on to see how you can track these evolving targets and stay ahead of the shifting...",
    "url": "https://finance.yahoo.com/news/recent-developments-reshaping-postal-realty-110807503.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6ac5db46-0330-3010-8f16-cffddebccd77",
      "content": {
        "id": "6ac5db46-0330-3010-8f16-cffddebccd77",
        "contentType": "STORY",
        "title": "How Recent Developments Are Reshaping The Postal Realty Trust Investment Story",
        "description": "",
        "summary": "Postal Realty Trust has seen its fair value estimate inch higher from $16.66 to $17.93 per share as analysts factor in faster rental income growth and better cash flow visibility across its portfolio. A modest drop in the discount rate from 7.94% to about 7.50% has also boosted the present value of expected cash flows, even as some forecasts still build in cautious assumptions on long term growth and risk. Read on to see how you can track these evolving targets and stay ahead of the shifting...",
        "pubDate": "2025-12-18T11:08:07Z",
        "displayTime": "2025-12-18T11:08:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/ea9a9eeeecb49307968d5202d20e6704",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1Tf8sdJJEIL9ZSK9w1qPhQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ea9a9eeeecb49307968d5202d20e6704.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TpgxbX4L9_VfQuV36680MA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/ea9a9eeeecb49307968d5202d20e6704.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-reshaping-postal-realty-110807503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-reshaping-postal-realty-110807503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PSTL"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T11:00:00+00:00",
    "headline": "Service Compression Announces $400 Million ABL Facility Upsize",
    "summary": "Service Compression, LLC (\"Service Compression\" or \"SC\"), a leading provider of natural gas compression services to exploration and production companies, today announced the successful upsize of its asset‑based loan (ABL) credit facility to $400 million, representing a $100 million increase from the prior facility. The upsized facility closed on December 17, 2025, and is led by J.P. Morgan.",
    "url": "https://finance.yahoo.com/news/compression-announces-400-million-abl-110000066.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "fd01ea82-c42f-3503-8344-a8ff8441c0ca",
      "content": {
        "id": "fd01ea82-c42f-3503-8344-a8ff8441c0ca",
        "contentType": "STORY",
        "title": "Service Compression Announces $400 Million ABL Facility Upsize",
        "description": "",
        "summary": "Service Compression, LLC (\"Service Compression\" or \"SC\"), a leading provider of natural gas compression services to exploration and production companies, today announced the successful upsize of its asset‑based loan (ABL) credit facility to $400 million, representing a $100 million increase from the prior facility. The upsized facility closed on December 17, 2025, and is led by J.P. Morgan.",
        "pubDate": "2025-12-18T11:00:00Z",
        "displayTime": "2025-12-18T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/03988d02bd64ebb560a505fbef63003d",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AjdvzABrPoZdU75xlDSz2Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/03988d02bd64ebb560a505fbef63003d.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DIBGkdz.H8yNMHnYu9nAQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/03988d02bd64ebb560a505fbef63003d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/compression-announces-400-million-abl-110000066.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/compression-announces-400-million-abl-110000066.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NG=F"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T10:30:00+00:00",
    "headline": "JPMorgan Quants Warn of ‘Extreme Crowding’ in Speculative Stocks",
    "summary": "The list includes Broadcom Inc., Advanced Micro Devices Inc., Expedia Group Inc., Estee Lauder Cos Inc., Invesco Ltd. and Nucor Corp.  The selloff has been led by tech shares as investors rotate out of winners — an event the JPMorgan quants warned about.",
    "url": "https://finance.yahoo.com/news/jpmorgan-quants-warn-extreme-crowding-103000458.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "12c68a3f-b9a0-33bd-b185-c804556a555a",
      "content": {
        "id": "12c68a3f-b9a0-33bd-b185-c804556a555a",
        "contentType": "STORY",
        "title": "JPMorgan Quants Warn of ‘Extreme Crowding’ in Speculative Stocks",
        "description": "",
        "summary": "The list includes Broadcom Inc., Advanced Micro Devices Inc., Expedia Group Inc., Estee Lauder Cos Inc., Invesco Ltd. and Nucor Corp.  The selloff has been led by tech shares as investors rotate out of winners — an event the JPMorgan quants warned about.",
        "pubDate": "2025-12-18T10:30:00Z",
        "displayTime": "2025-12-18T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-12/41b598a0-dc06-11f0-9ffd-07684ae70b4b",
          "originalWidth": 4000,
          "originalHeight": 2667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sLRhQdRWRwboq1ZwZ_BaQQ--~B/aD0yNjY3O3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-12/41b598a0-dc06-11f0-9ffd-07684ae70b4b.cf.webp",
              "width": 4000,
              "height": 2667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NCKMJkXrhQR8hUoG2l0L0Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-12/41b598a0-dc06-11f0-9ffd-07684ae70b4b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-quants-warn-extreme-crowding-103000458.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-quants-warn-extreme-crowding-103000458.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "EXPE"
            },
            {
              "symbol": "IVZ"
            },
            {
              "symbol": "NUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T09:15:49+00:00",
    "headline": "JPMorgan’s tokenized dollars are quietly rewiring how Wall Street moves money",
    "summary": "The Wall Street titan’s recent embrace of a public blockchain is a harbinger of things to come.",
    "url": "https://www.coindesk.com/business/2025/12/18/jpmorgan-s-tokenized-dollars-are-quietly-rewiring-how-wall-street-moves-money",
    "source": "CoinDesk",
    "provider": "yfinance",
    "raw": {
      "id": "61b0f685-4aed-3b9a-b079-068c0c11dea4",
      "content": {
        "id": "61b0f685-4aed-3b9a-b079-068c0c11dea4",
        "contentType": "STORY",
        "title": "JPMorgan’s tokenized dollars are quietly rewiring how Wall Street moves money",
        "description": "",
        "summary": "The Wall Street titan’s recent embrace of a public blockchain is a harbinger of things to come.",
        "pubDate": "2025-12-18T09:15:49Z",
        "displayTime": "2025-12-18T09:15:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/coindesk_75/5e3a58699aaf2fa8b34129fe1341f237",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iND2_pHdQvK2LJD8Fssmqg--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/coindesk_75/5e3a58699aaf2fa8b34129fe1341f237.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VZJzDMAI2xVuvBrYOKlRzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/coindesk_75/5e3a58699aaf2fa8b34129fe1341f237.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CoinDesk",
          "url": "https://www.coindesk.com"
        },
        "canonicalUrl": {
          "url": "https://www.coindesk.com/business/2025/12/18/jpmorgan-s-tokenized-dollars-are-quietly-rewiring-how-wall-street-moves-money",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-tokenized-dollars-quietly-rewiring-091549280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "COIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T05:02:00+00:00",
    "headline": "Are Model Portfolios Key to Alt Adoption?",
    "summary": "Many advisors are unfamiliar with alternatives, like private assets, but model portfolios could be the perfect entryway.",
    "url": "https://www.thedailyupside.com/advisor/investing-strategies/are-model-portfolios-key-to-alt-adoption/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "03052baf-b8c5-366c-a3c1-e5da9bc5c74d",
      "content": {
        "id": "03052baf-b8c5-366c-a3c1-e5da9bc5c74d",
        "contentType": "STORY",
        "title": "Are Model Portfolios Key to Alt Adoption?",
        "description": "",
        "summary": "Many advisors are unfamiliar with alternatives, like private assets, but model portfolios could be the perfect entryway.",
        "pubDate": "2025-12-18T05:02:00Z",
        "displayTime": "2025-12-18T05:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/8138fa536f9c33a34165372ad8002bd8",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Models on a fashion runway.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/neNRpvLHSHHxFqnqUzbY2Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/8138fa536f9c33a34165372ad8002bd8.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_ZoGP_5qFXkmPRfQGuq_sw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/8138fa536f9c33a34165372ad8002bd8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/advisor/investing-strategies/are-model-portfolios-key-to-alt-adoption/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/model-portfolios-key-alt-adoption-050200339.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SCHW"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "IVZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T04:33:37+00:00",
    "headline": "3 S&P 500 Stocks We Steer Clear Of",
    "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
    "url": "https://finance.yahoo.com/news/3-p-500-stocks-steer-043337211.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "d6db5b0b-6583-3028-aa2f-0c5e9fba8065",
      "content": {
        "id": "d6db5b0b-6583-3028-aa2f-0c5e9fba8065",
        "contentType": "STORY",
        "title": "3 S&P 500 Stocks We Steer Clear Of",
        "description": "",
        "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
        "pubDate": "2025-12-18T04:33:37Z",
        "displayTime": "2025-12-18T04:33:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/418881b62ba3b43e09520fba3ca0350e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "TPR Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JlvXoNRO8lcHNBdITvrGYA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/418881b62ba3b43e09520fba3ca0350e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ELvJjCwXOarjlhflkEgo3g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/418881b62ba3b43e09520fba3ca0350e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-p-500-stocks-steer-043337211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-p-500-stocks-steer-043337211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "HIG"
            },
            {
              "symbol": "TPR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T02:11:39+00:00",
    "headline": "Why Analysts See the D-Market Story Shifting After Reset Price Target and Strategy Changes",
    "summary": "D Market Elektronik Hizmetler ve Ticaret has seen its near term price target reset to $3.07, even as fair value remains anchored at $3.47 per share. Analysts frame this shift as a recalibration toward execution risk, with growth initiatives around customer and merchant acquisition expected to pay off later rather than sooner. Read on to see how you can track these evolving expectations and stay updated on the changing narrative around the stock. Analyst Price Targets don't always capture the...",
    "url": "https://finance.yahoo.com/news/why-analysts-see-d-market-021139709.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "454b1309-ef60-3611-bb2d-51a385b84b37",
      "content": {
        "id": "454b1309-ef60-3611-bb2d-51a385b84b37",
        "contentType": "STORY",
        "title": "Why Analysts See the D-Market Story Shifting After Reset Price Target and Strategy Changes",
        "description": "",
        "summary": "D Market Elektronik Hizmetler ve Ticaret has seen its near term price target reset to $3.07, even as fair value remains anchored at $3.47 per share. Analysts frame this shift as a recalibration toward execution risk, with growth initiatives around customer and merchant acquisition expected to pay off later rather than sooner. Read on to see how you can track these evolving expectations and stay updated on the changing narrative around the stock. Analyst Price Targets don't always capture the...",
        "pubDate": "2025-12-18T02:11:39Z",
        "displayTime": "2025-12-18T02:11:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/992331fc596d921e34ccfa3b8813259a",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TgQaHUfmmHon5Jw1kV.7ZA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/992331fc596d921e34ccfa3b8813259a.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0yy3wCt7QRaIzabP_8j8Gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/992331fc596d921e34ccfa3b8813259a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-d-market-021139709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-d-market-021139709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HEPS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]